1. Home
  2. SANG vs ACHV Comparison

SANG vs ACHV Comparison

Compare SANG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

N/A

Current Price

$4.77

Market Cap

151.1M

Sector

Technology

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

SELL

Current Price

$6.75

Market Cap

726.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SANG
ACHV
Founded
1984
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
726.5M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
SANG
ACHV
Price
$4.77
$6.75
Analyst Decision
Sell
Strong Buy
Analyst Count
3
12
Target Price
$5.12
★ $14.15
AVG Volume (30 Days)
67.1K
★ 1.3M
Earning Date
11-05-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.57
N/A
Revenue Next Year
$1.61
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.40
$2.62
52 Week High
$5.42
$8.64

Technical Indicators

Market Signals
Indicator
SANG
ACHV
Relative Strength Index (RSI) 62.44 47.88
Support Level $4.71 $5.96
Resistance Level $5.02 $7.29
Average True Range (ATR) 0.13 0.40
MACD -0.00 0.03
Stochastic Oscillator 79.17 50.96

Price Performance

Historical Comparison
SANG
ACHV

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic location USA and Other countries. Key revenue is generated from USA.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: